ConductScience.org, home

Paper2242008

R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.

Vanden Bossche H and 8 others. Biochem Pharmacol, 1990. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis. Papers, record 2242008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2242008

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2019-06-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vanden Bossche HH
2Willemsens GG
3Roels II
4Bellens DD
5Moereels HH
6Coene MCM C
7Le Jeune LL
8Lauwers WW
9Janssen PAP A

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aromatase InhibitorsMajor topic
Cytochrome P-450 Enzyme InhibitorsMajor topic
EstrogensMajor topic
TriazolesMajor topic
Adrenal Glands
Androgens
Androstenedione
Animals
Cattle
Female
Male
Microsomes
Placenta
Rabbits
Rats
Spectrophotometry
Stereoisomerism
Swine
Testis

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
35719693Synthesis of Triarylmethanes via Palladium-Catalyzed Suzuki-Miyaura Reactions of Diarylmethyl Esters.Organometallics2021https://conductscience.org/library/papers/35719693PubMed
31757843Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer.J Nucl Med2020https://conductscience.org/library/papers/31757843PubMed
31404334Reliable Target Prediction of Bioactive Molecules Based on Chemical Similarity Without Employing Statistical Methods.Front Pharmacol2019https://conductscience.org/library/papers/31404334PubMed
26635974Determining the IC 50 Values for Vorozole and Letrozole, on a Series of Human Liver Cytochrome P450s, to Help Determine the Binding Site of Vorozole in the Liver.Enzyme Res2015https://conductscience.org/library/papers/26635974PubMed
26456904In vivo visualization of aromatase in animals and humans.Front Neuroendocrinol2016https://conductscience.org/library/papers/26456904PubMed
25152615Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives.Drug Des Devel Ther2014https://conductscience.org/library/papers/25152615PubMed
21608133Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.ChemMedChem2011https://conductscience.org/library/papers/21608133PubMed
20842717Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole.Synapse2010https://conductscience.org/library/papers/20842717PubMed
19217534Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug.Nucl Med Biol2009https://conductscience.org/library/papers/19217534PubMed
15328084The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15328084PubMed
11870544Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.Br J Cancer2002https://conductscience.org/library/papers/11870544PubMed
10947967Kinetic and stereochemical studies on novel inactivators of C-terminal amidation.Biochem J2000https://conductscience.org/library/papers/10947967PubMed
10473018Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.Drugs1999https://conductscience.org/library/papers/10473018PubMed
9484813Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.Br J Cancer1998https://conductscience.org/library/papers/9484813PubMed
7949204Aromatase inhibitors--mechanisms for non-steroidal inhibitors.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7949204PubMed
7749129Aromatase inhibitor development for treatment of breast cancer.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7749129PubMed
7726994Vorozole, a specific non-steroidal aromatase inhibitor.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7726994PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
CYP2B61555PubTator's text mininghttps://conductscience.org/library/genes/1555NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2242008

GET https://conductscience.org/api/papers/v1/2242008/authors